Sectoral Asset Management as of March 31, 2019
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 106 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 5.5 | $46M | 3.4M | 13.60 | |
Aerie Pharmaceuticals | 4.8 | $40M | 840k | 47.50 | |
Alnylam Pharmaceuticals (ALNY) | 4.4 | $37M | 391k | 93.45 | |
Apellis Pharmaceuticals (APLS) | 4.0 | $34M | 1.7M | 19.50 | |
Teladoc (TDOC) | 4.0 | $33M | 592k | 55.60 | |
Shockwave Med | 3.4 | $28M | 850k | 33.47 | |
Gilead Sciences (GILD) | 3.4 | $28M | 436k | 65.01 | |
Array BioPharma | 2.7 | $22M | 910k | 24.38 | |
Portola Pharmaceuticals | 2.5 | $21M | 609k | 34.70 | |
Novartis (NVS) | 2.4 | $20M | 204k | 96.14 | |
Pfizer (PFE) | 2.1 | $18M | 419k | 42.47 | |
Ptc Therapeutics I (PTCT) | 2.1 | $17M | 463k | 37.64 | |
Celgene Corporation | 2.0 | $17M | 180k | 94.34 | |
Hill-Rom Holdings | 2.0 | $17M | 159k | 105.86 | |
Wright Medical Group Nv | 1.9 | $16M | 501k | 31.45 | |
Ra Pharmaceuticals | 1.9 | $15M | 687k | 22.40 | |
Sarepta Therapeutics (SRPT) | 1.8 | $15M | 128k | 119.19 | |
Evolent Health (EVH) | 1.8 | $15M | 1.2M | 12.58 | |
Eli Lilly & Co. (LLY) | 1.7 | $15M | 112k | 129.76 | |
Global Blood Therapeutics In | 1.7 | $15M | 273k | 52.93 | |
Assembly Biosciences | 1.7 | $14M | 716k | 19.69 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.7 | $14M | 934k | 15.14 | |
Merck & Co (MRK) | 1.6 | $14M | 165k | 83.17 | |
Acceleron Pharma | 1.5 | $13M | 269k | 46.57 | |
Allergan | 1.5 | $12M | 85k | 146.41 | |
Vocera Communications | 1.4 | $12M | 382k | 31.63 | |
La Jolla Pharmaceuticl Com Par | 1.4 | $11M | 1.8M | 6.43 | |
AtriCure (ATRC) | 1.3 | $11M | 393k | 26.79 | |
Bristol Myers Squibb (BMY) | 1.3 | $10M | 219k | 47.71 | |
R1 Rcm | 1.3 | $11M | 1.1M | 9.67 | |
Medtronic (MDT) | 1.1 | $9.5M | 104k | 91.08 | |
Boston Scientific Corporation (BSX) | 1.1 | $9.3M | 242k | 38.38 | |
Insulet Corporation (PODD) | 1.0 | $8.6M | 91k | 95.09 | |
Tandem Diabetes Care (TNDM) | 1.0 | $8.6M | 136k | 63.50 | |
UnitedHealth (UNH) | 1.0 | $8.5M | 35k | 247.27 | |
Viewray (VRAYQ) | 1.0 | $8.3M | 1.1M | 7.39 | |
Obseva Sa | 1.0 | $8.0M | 629k | 12.79 | |
Abbott Laboratories (ABT) | 0.9 | $7.8M | 98k | 79.94 | |
Albireo Pharma | 0.9 | $7.8M | 243k | 32.21 | |
D Stemline Therapeutics | 0.9 | $7.7M | 596k | 12.85 | |
HMS Holdings | 0.9 | $7.5M | 255k | 29.61 | |
Forty Seven | 0.9 | $7.5M | 467k | 16.16 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $7.1M | 80k | 88.83 | |
Unum Therapeutics Ord | 0.8 | $7.0M | 1.6M | 4.39 | |
Glycomimetics (GLYC) | 0.8 | $6.8M | 548k | 12.46 | |
Savara (SVRA) | 0.8 | $6.6M | 896k | 7.37 | |
Cigna Corp (CI) | 0.8 | $6.6M | 41k | 160.82 | |
Abiomed | 0.8 | $6.4M | 22k | 285.59 | |
Irhythm Technologies (IRTC) | 0.7 | $6.2M | 83k | 74.96 | |
Zimmer Holdings (ZBH) | 0.7 | $6.1M | 48k | 127.70 | |
Intec Pharma | 0.7 | $5.9M | 809k | 7.33 | |
Nightstar Therapeutics | 0.7 | $5.9M | 234k | 25.37 | |
Adamas Pharmaceuticals | 0.7 | $5.8M | 809k | 7.11 | |
Meiragtx Holdings (MGTX) | 0.7 | $5.5M | 321k | 17.23 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $5.3M | 43k | 125.26 | |
Evelo Biosciences | 0.6 | $5.2M | 651k | 8.00 | |
Sage Therapeutics (SAGE) | 0.6 | $5.0M | 32k | 159.05 | |
Inspire Med Sys (INSP) | 0.6 | $4.9M | 86k | 56.78 | |
WellCare Health Plans | 0.5 | $4.4M | 16k | 269.77 | |
Fibrogen (FGEN) | 0.5 | $4.4M | 81k | 54.34 | |
Agios Pharmaceuticals (AGIO) | 0.5 | $4.0M | 60k | 67.43 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $3.7M | 20k | 183.96 | |
EXACT Sciences Corporation (EXAS) | 0.4 | $3.3M | 38k | 86.61 | |
Spring Bk Pharmaceuticals In | 0.3 | $2.9M | 277k | 10.49 | |
Proteostasis Therapeutics In | 0.3 | $2.6M | 2.1M | 1.26 | |
Johnson & Johnson (JNJ) | 0.3 | $2.5M | 18k | 139.78 | |
Urogen Pharma (URGN) | 0.3 | $2.4M | 65k | 36.93 | |
Molecular Templates | 0.2 | $2.0M | 350k | 5.81 | |
Beigene | 0.2 | $1.4M | 11k | 131.97 | |
Thermo Fisher Scientific (TMO) | 0.1 | $1.2M | 4.5k | 273.69 | |
Anthem (ELV) | 0.1 | $965k | 3.4k | 287.12 | |
Hutchison China Meditech (HCM) | 0.1 | $967k | 32k | 30.57 | |
Dr. Reddy's Laboratories (RDY) | 0.1 | $798k | 20k | 40.51 | |
Becton, Dickinson and (BDX) | 0.1 | $753k | 3.0k | 249.75 | |
Hca Holdings (HCA) | 0.1 | $693k | 5.3k | 130.36 | |
Dermira | 0.1 | $568k | 42k | 13.56 | |
Humana (HUM) | 0.1 | $490k | 1.8k | 266.16 | |
Kalvista Pharmaceuticals (KALV) | 0.1 | $502k | 18k | 28.60 | |
Universal Health Services (UHS) | 0.1 | $385k | 2.9k | 133.63 | |
Spark Therapeutics | 0.1 | $405k | 3.6k | 113.96 | |
Blueprint Medicines (BPMC) | 0.0 | $335k | 4.2k | 80.07 | |
Zai Lab (ZLAB) | 0.0 | $372k | 13k | 29.55 | |
Centene Corporation (CNC) | 0.0 | $222k | 4.2k | 53.11 | |
Acelrx Pharmaceuticals | 0.0 | $257k | 74k | 3.48 | |
Chemocentryx | 0.0 | $247k | 18k | 13.87 | |
Myokardia | 0.0 | $211k | 4.1k | 52.09 | |
Sierra Oncology | 0.0 | $240k | 140k | 1.71 | |
ImmunoGen | 0.0 | $157k | 58k | 2.71 | |
Antares Pharma | 0.0 | $143k | 47k | 3.02 | |
Mei Pharma | 0.0 | $137k | 45k | 3.08 | |
Cytokinetics (CYTK) | 0.0 | $126k | 16k | 8.09 | |
Revance Therapeutics (RVNC) | 0.0 | $177k | 11k | 15.76 | |
Quotient | 0.0 | $159k | 18k | 9.01 | |
Kura Oncology (KURA) | 0.0 | $196k | 12k | 16.61 | |
Protagonist Therapeutics (PTGX) | 0.0 | $143k | 11k | 12.54 | |
Biohaven Pharmaceutical Holding | 0.0 | $201k | 3.9k | 51.54 | |
Biolinerx Ltd-spons | 0.0 | $77k | 178k | 0.43 | |
Tetraphase Pharmaceuticals | 0.0 | $53k | 40k | 1.33 | |
Marinus Pharmaceuticals | 0.0 | $70k | 17k | 4.17 | |
Abeona Therapeutics | 0.0 | $93k | 13k | 7.33 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $67k | 25k | 2.63 | |
Cytomx Therapeutics (CTMX) | 0.0 | $108k | 10k | 10.74 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $51k | 13k | 4.05 | |
Aeglea Biotherapeutics | 0.0 | $104k | 13k | 8.03 | |
Nabriva Therapeutics | 0.0 | $93k | 38k | 2.43 | |
Clearside Biomedical (CLSD) | 0.0 | $36k | 26k | 1.39 |